Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam + fentanyl for procedural sedation in anterior shoulder dislocation reduction
IRCT2016021726611N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in anterior shoulder dislocation comparing Dexmedetomidine with Midazolam + fentanyl (2 arms). Primary endpoints: sedation and analgesia. Started Feb 2016; status: completed.
02
Drugs
dexmedetomidinemidazolamfentanyl
03
Conditions
anterior shoulder dislocation
Beyond the preview
Go deeper on IRCT2016021726611N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016021726611N1.